Monitoring interval cancers in mammographic screening: The Florence District programme experience

Breast

Volumn 11, Issue 4, 2002, Pages 301-305

  Zappa, M ^a   Falini, P ^a   Bonardi, R ^a   Ambrogetti, D ^a   Giorgi, D ^a   Paci, E ^a   Ciatto, S ^a  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DATA ANALYSIS; ECHOMAMMOGRAPHY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; UNITED STATES;

EID: 0036700576     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2002.0437     Document Type: Article

References (15)

1. Day N E, Williams D R R, Khaw K T. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989; 59: 954-958.
2. Woodman C B J, Threlfall A G, Boggis C R M et al. Is the three year breast cancer screening interval too long? Occurrence of interval cancers in NHS breast cancer screening programme's north western region. Br Med J 1995; 310: 224-226.
3. Day N E, Mc Cann J, Camilleri-Ferrante C et al. On behalf of the Quality Assurance Management Group of the East Anglia Breast Screening Programme. Monitoring interval cancers in breast screening programmes. J Med Screen 1995; 2: 180-185.
4. Franchebaud J, de Koenig H J, Beemsterboer P M, Boer R, verbeek A J H, van Ineveld B M, Broeders M J, de Bruyn A E, van der Maas P J. Interval cancers in the Dutch breast Cancer screening programme. Br J Cancer 1999; 81(5): 912-917.
5. Mammographic screening Evaluation group, HS Copenhagen Hospital Corporation. Mammographic screening for breast cancer in Copenhagen. April 1991-March 1997. Acta Pathol, Microbiol Immunol Scand 1999; 106 (Suppl 83): 210-224.
6. Everington D, Gilbert F J, Tyack C et al. The Scottish breast screening programme's experience of monitoring interval cancers. J Med Screen 1999; 6: 21-27.
7. Tabar L, Faberger G, Day N E et al. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast screening programme. Br J Cancer 1987; 59: 929-932.
8. Ciatto S, Cecchini S, Rosselli Del Turco M et al. Referral policy and positive predictive value of call for surgical biopsy in the Florence Breast Cancer Screening Program. J Clin Epidemiol 1990; 43: 5419-5423.
9. Paci E, Ciatto S, Buiatti E et al. Early indicators of efficacy of breast cancer screening programmes. Results of the Florence District Programme. Int J Cancer 1990; 46: 198-202.
10. Ciatto S, Rosselli Del Turco M, Giorgi D et al. Assessment of lesions detected at mammographic screening: performance at first or repeat screening in the Florence programme. J Med Screen 1994; 1: 188-192.
11. Ciatto S, Rosselli Del Turco M, Zappa M. The detectability of breast cancer by screening mammography. Br J Cancer 1995; 71: 337-339.
12. Ciatto S, Rosselli Del Turco M, Ambrogetti D et al. Solid nonpalpable lesions. Success and failure of guided fine needle aspiration cytology in a consecutive series of 2444 cases. Acta Radiol 1997 38: 815-820.
13. Sala E, Warren R, Mc Cann J et al. Mammographic parenchymal pattern and mode of detection: implication for the breast screening programme. J Med Screen 1998; 5: 207-212.
14. Bjurstam N, Bjorneld L, Duffy S W. The Gothemburg Breast Screening Trial. First results on mortality, incidence, and mode of detection for women aged 39-49 years at randomisation. Cancer 1997; 80: 2091-2099.
15. Exbrayat C, Gamier A, Colonna M, Assouline D, Salicru B, Wicnkel P, Menegoz F, Bolla M. Analysis and classification of interval cancers in a French breast caneer screening programme. Eur J Cancer Prev 1999; 8: 255-260.